Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-11

Clinical Trial Update: Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study evaluating activated allogeneic lymphocytes to induce a graft-versus-tumor effect in metastatic solid tumors, including metastatic breast cancer a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Activated allogeneic lymphocytes

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Metastatic Breast Cancer, Malignant Melanoma | Phase 2 | Status: COMPLETED